CIAM
FLNA

Caitong International Asset Management’s Filana Therapeutics FLNA Stock Holding History

Caitong International Asset Management’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$181 Sell
107
-13,499
-99% -$27.8K ﹤0.01% 1899
2025
Q4 		$26.9K Buy
13,606
+11,200
+466% +$35.9K 0.01% 922
2025
Q3 		$7K Sell
2,406
-4,086
-63% -$9.4K ﹤0.01% 1128
2025
Q2 		$11.8K Buy
6,492
+5,320
+454% +$9.47K 0.01% 663
2025
Q1 		$1.76K Buy
+1,172
New +$2.96K ﹤0.01% 1402

Other funds holding FLNA

Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Caitong International Asset Management's FLNA Position: Q1 2026 in Review

Caitong International Asset Management reduced its Filana Therapeutics (FLNA) stake by 99% in Q1 2026, selling an estimated $27.8K and leaving 107 shares worth $181. The position accounts for ﹤0.01% of the portfolio, ranked #1899.

Caitong International Asset Management first reported a position in FLNA in Q1 2025 and has held it in 5 quarters since. The position peaked at $26.9K in Q4 2025. 101 funds tracked by Wall St. Rank hold FLNA as of Q1 2026.

  • Caitong International Asset Management held 107 shares of Filana Therapeutics worth $181 as of Q1 2026.
  • Caitong International Asset Management sold 13,499 Filana Therapeutics shares in Q1 2026, an estimated $27.8K.
  • Filana Therapeutics made up ﹤0.01% of Caitong International Asset Management's portfolio in Q1 2026, its #1899 holding.
  • Caitong International Asset Management first reported a position in Filana Therapeutics in Q1 2025 and has held it in 5 quarters since.
  • Caitong International Asset Management's Filana Therapeutics position peaked at $26.9K in Q4 2025.
  • 101 funds tracked by Wall St. Rank held Filana Therapeutics as of Q1 2026.

Based on Caitong International Asset Management's 13F filing for Q1 2026, filed 11 May 2026.